Skip to main content
TipRanks
Go Ultimate75% OFF

DaVita (DVA) Revenue by Segment

1,102 Followers

Revenue by Segment

DaVita reported revenue by segment of $3.58B in Q3 2026, up 0.7% from Q2 2026 and up 4.6% year over year. The highest value was $3.62B in Q4 2025.

Breaks down income across different business areas, showing where the company is earning the most and identifying growth or risk areas.

-$1.00B$0.00$1.00B$2.00B$3.00BMar 21Jun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
Chart Insights

Dialysis remains the revenue engine but is growing steadily rather than explosively, while Ancillary Services has accelerated and is becoming a material diversification lever that will support margins over time; Eliminations are immaterial noise. Management’s call reinforces this: treatment volumes are picking up and IKC/International add modest OI, and cost savings from phosphate‑binder changes and expanded‑HD deployment should amplify ancillary economics. Near‑term risks—ACA mix pressure on revenue‑per‑treatment and elevated patient‑care cost growth—could temper margin upside despite the stronger ancillary trend.

DVA Revenue by Segment

PeriodEliminationsDialysisAncillary ServicesTotal
Q3 2026Sep 30, 2026-$24.12M$3.05B$551.77M$3.58B
Q2 2026Jun 30, 2026-$14.00M$3.01B$557.00M$3.56B
Q1 2026Mar 31, 2026-$24.00M$2.94B$498.00M$3.42B
Q4 2025Dec 31, 2025-$23.00M$3.08B$567.00M$3.62B
Q3 2025Sep 30, 2025-$14.70M$2.98B$454.89M$3.42B
Q2 2025Jun 30, 2025-$20.00M$2.91B$486.00M$3.38B
Q1 2025Mar 31, 2025-$14.00M$2.82B$415.00M$3.22B
Q4 2024Dec 31, 2024-$23.00M$2.89B$430.00M$3.29B
Q3 2024Sep 30, 2024-$19.00M$2.91B$376.00M$3.26B
Q2 2024Jun 30, 2024-$17.00M$2.84B$362.00M$3.19B
Q1 2024Mar 31, 2024-$27.00M$2.76B$342.00M$3.07B
Q4 2023Dec 31, 2023-$24.00M$2.81B$360.00M$3.15B
Q3 2023Sep 30, 2023-$27.00M$2.79B$363.00M$3.12B
Q2 2023Jun 30, 2023-$22.00M$2.73B$292.00M$3.00B
Q1 2023Mar 31, 2023-$23.00M$2.61B$284.00M$2.87B
Q4 2022Dec 31, 2022-$27.00M$2.66B$285.00M$2.92B
Q3 2022Sep 30, 2022-$23.00M$2.70B$268.00M$2.95B
Q2 2022Jun 30, 2022-$19.00M$2.66B$283.00M$2.93B
Q1 2022Mar 31, 2022-$22.00M$2.58B$265.00M$2.82B
Q4 2021Dec 31, 2021-$21.00M$2.70B$263.00M$2.94B
Q3 2021Sep 30, 2021-$22.00M$2.70B$262.00M$2.94B
Q2 2021Jun 30, 2021-$21.00M$2.68B$261.00M$2.92B
Q1 2021Mar 31, 2021-$31.00M$2.59B$261.00M$2.82B
Q4 2020Dec 31, 2020-$45.00M$2.67B$276.00M$2.90B
Q3 2020Sep 30, 2020-$41.00M$2.69B$271.00M$2.92B
Q2 2020Jun 30, 2020-$40.00M$2.67B$245.00M$2.88B
Q1 2020Mar 31, 2020-$36.00M$2.62B$261.00M$2.84B

Related KPIs